Literature DB >> 2988399

Adenocarcinoma of the extrahepatic biliary tree.

J B Anderson, M J Cooper, R C Williamson.   

Abstract

Increasing survival rates for carcinoma of the biliary tree could reflect the selection of patients for referral to a specialist centre as well as modern improvements in diagnosis and treatment. To determine the true incidence and outcome of biliary cancer, the records of 243 unselected Bristol patients were reviewed retrospectively over a 15-year period. Mean age was 64 years. Gallstones were associated in 38% of cases. Sixty-nine of 87 patients with gallbladder carcinoma were submitted to laparotomy. The operative (30-day) mortality rate was 56% and the one-year survival rate was 7%; one patient with an unexpected carcinoma is alive 7 years after cholecystectomy (1% five-year survival rate). Among 31 patients with carcinoma of the ampulla the operative mortality rate was 27%; one-year and five-year survival rates were 46% and 15%. Bile duct cancers (n = 125) arose proximal to the entry of the cystic duct (n = 63), distal to that point (n = 46) or diffusely (n = 16). For proximal cholangiocarcinoma the operative mortality rate was 38% and 1-year survival rate 17%; no patient lived for 2 years. For distal cholangiocarcinoma the operative mortality rate was 45% and one-year survival rate 26%; no patient lived for 3 years. Only palliative procedures were undertaken for diffuse cholangiocarcinoma; 2 patients survived 1 year (13%). Overall 5 patients with carcinoma of the extrahepatic biliary tree appear to have been cured (2%).

Entities:  

Mesh:

Year:  1985        PMID: 2988399      PMCID: PMC2498035     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  24 in total

Review 1.  Carcinoma of the proximal extrahepatic biliary tree. Definitive and palliative treatment.

Authors:  J Terblanche
Journal:  Surg Annu       Date:  1979

2.  Hepatic transplantation.

Authors:  T E Starzl
Journal:  Surgery       Date:  1976-06       Impact factor: 3.982

3.  Carcinoma of the extrahepatic biliary tract.

Authors:  W P Longmire; M S McArthur; E A Bastounis; J Hiatt
Journal:  Ann Surg       Date:  1973-09       Impact factor: 12.969

4.  Proximal bile duct tumors: surgical management with silastic transhepatic biliary stents.

Authors:  J L Cameron; P Broe; G D Zuidema
Journal:  Ann Surg       Date:  1982-10       Impact factor: 12.969

5.  Carcinoma of the gallbladder.

Authors:  J Koo; J Wong; F C Cheng; G B Ong
Journal:  Br J Surg       Date:  1981-03       Impact factor: 6.939

6.  Carcinoma of the gallbladder.

Authors:  T R Kelly; T R Chamberlain
Journal:  Am J Surg       Date:  1982-06       Impact factor: 2.565

7.  Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver.

Authors:  H Bismuth; M B Corlette
Journal:  Surg Gynecol Obstet       Date:  1975-02

8.  Pancreaticoduodenectomy. A 40-year experience.

Authors:  J R Cohen; N Kuchta; N Geller; G T Shires; P Dineen
Journal:  Ann Surg       Date:  1982-05       Impact factor: 12.969

9.  Is carcinoma of the gallbladder a curable lesion?

Authors:  H J Wanebo; W N Castle; R E Fechner
Journal:  Ann Surg       Date:  1982-05       Impact factor: 12.969

10.  Adenocarcinoma of the ampulla of Vater. Diagnosis and treatment.

Authors:  D B Walsh; F E Eckhauser; J L Cronenwett; J G Turcotte; S M Lindenauer
Journal:  Ann Surg       Date:  1982-02       Impact factor: 12.969

View more
  6 in total

1.  Diagnostic difficulties in patients with a pancreatic mass.

Authors:  M R Zeiderman; A Wyman; H A Euinton; J M Simms; K Rogers
Journal:  BMJ       Date:  1991-06-08

2.  Growth factor receptors are differentially expressed in cancers of the papilla of vater and pancreas.

Authors:  H Friess; L Wang; Z Zhu; R Gerber; M Schröder; A Fukuda; A Zimmermann; M Korc; M W Büchler
Journal:  Ann Surg       Date:  1999-12       Impact factor: 12.969

Review 3.  Acalculous disease of the gall bladder.

Authors:  R C Williamson
Journal:  Gut       Date:  1988-06       Impact factor: 23.059

4.  DNA aneuploidy is an independent factor of poor prognosis in pancreatic and peripancreatic cancer.

Authors:  S Sciallero; W Giaretti; E Geido; L Bonelli; L Zhankui; S Saccomanno; E Zeraschi; V Pugliese
Journal:  Int J Pancreatol       Date:  1993-08

5.  Differential c-erbB-1 and c-erbB-2 mRNA expression in cancer of the pancreas compared with cancer of the papilla of Vater.

Authors:  Klaus L Prenzel; Ute Warnecke-Eberz; Jan Brabender; Stephan E Baldus; Elfriede Bollschweiler; Christian A Gutschow; Uta Drebber; Arnulf H Hoelscher; Paul M Schneider
Journal:  World J Gastroenterol       Date:  2006-01-21       Impact factor: 5.742

6.  Atypical presentation of an advanced obstructive biliary cancer without jaundice.

Authors:  Vincent Bryan Salvador; Pushkinder Samrao; Anatoly Leytin; Mohammed Basith
Journal:  Am J Case Rep       Date:  2013-11-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.